Journal of Neurochemistry · 2002 · 51 citations · 32 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyCannabinoid PharmacologyLigand BindingNeurotransmissionNeurotransmitter ReceptorsReceptor PharmacologySerotonergic PharmacologyCannabinoid AgonistsCannabinoid Receptor ModulationCannabinoid Receptor PharmacologyDissociation EffectsRadioligand Binding AssaysRadioligand Pharmacodynamics
Cross-talk between cannabinoid CB1 and serotonin 5-HT receptors in rat cerebellar membranes was investigated using radioligand binding. In competition against the CB1 antagonist, [3 H]SR141716A, the agonist, WIN 55,212-2 yielded a biphasic isotherm. The majority of binding was to a high-affinity state that was significantly reduced by the GTP analogue, Gpp(NH)p. Interestingly, 5-HT enhanced the high-affinity binding constant of WIN 55,212-2 while attenuating the proportion of high-affinity binding. 5-HT also significantly reduced the proportion of high-affinity binding of the cannabinoid agonist, HU 210, but had no effect on the agonist, CP 55,940. The effect of 5-HT on WIN 55,212-2 binding was inhibited by the 5-HT2 receptor antagonist ritanserin as well as Gpp(NH)p, suggesting a dependence on the 5-HT2 receptor and on G protein-receptor interactions, respectively. Subsequent [3 H]WIN 55,212-2 dissociation kinetic experiments revealed that 5-HT promoted a slower-dissociating species of radiolabelled agonist-receptor complex. Our findings support a membrane-delimited cross-talk between two G protein-coupled receptors that are co-localized in certain cells of the central nervous system. Intriguingly, the cannabinoid agonist dependence of the 5-HT modulatory effect suggests that agonist-specific conformations of the CB1 receptor may also be important in determining the extent of this cross-talk.
32
Determination and characterization of a cannabinoid receptor in rat brain.
William A. Devane, F A Dysarz, M R Johnson et al. · Molecular Pharmacology · 1988 · 2.4K citations
Medicine, Neuroscience, Pharmacology +12
Cannabinoid receptor localization in brain.
Miles Herkenham, A B Lynn, M.D. Little et al. · Proceedings of the National Academy of Sciences · 1990 · 2.3K citations